Cargando…

Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report

Detalles Bibliográficos
Autores principales:	Osawa, Eduardo Atsushi, Brandão, Antonio Adolfo Guerra Soares, Dias Américo, André, Maciel, Alexandre Toledo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885376/ https://www.ncbi.nlm.nih.gov/pubmed/33039383 http://dx.doi.org/10.1016/j.htct.2020.05.008

Ejemplares similares

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018)

Fondaparinux for intra and perioperative anticoagulation in patients with heparin-induced thrombocytopenia candidates for peripheral vascular surgery: Report of 4 cases
por: Illuminati, Giulio, et al.
Publicado: (2016)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011)

Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
por: Linkins, Lori‐Ann, et al.
Publicado: (2018)

Fondaparinux sodium/heparin: Type II heparin-induced thrombocytopenia and drug cross reactivity: case report
Publicado: (2022)

Management of Heparin-Induced Thrombocytopenia with Fondaparinux in a Patient with Left Ventricular Assist Device
por: Velagic, V., et al.
Publicado: (2014)

Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report
por: He, Yumiao, et al.
Publicado: (2018)

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol
por: Ghaziri, Dania, et al.
Publicado: (2023)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2009)

Analysis of Leukocyte Recruitment in Continuous Veno-Venous Hemofiltration with Regional Citrate vs. Systemic Heparin Anticoagulation
por: Margraf, Andreas, et al.
Publicado: (2022)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
por: Christopher, Amy
Publicado: (2016)

Anticoagulation With Platelet Transfusions for Acute Limb Ischemia With Severe Thrombocytopenia
por: Shakfeh, Khalid, et al.
Publicado: (2023)

A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients
por: Benken, Scott T, et al.
Publicado: (2014)

A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux
por: Koul, AN
Publicado: (2015)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Acute Limb Ischemia Complicated by Heparin-Induced Thrombocytopenia in an Asymptomatic COVID-19 Patient
por: Siddiqui, Nabeel A, et al.
Publicado: (2021)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Azd-1222/fondaparinux-sodium/heparin: Vaccine-induced immune thrombotic thrombocytopenia (VIIT), aggravation of VIIT and lack of efficacy: case report
Publicado: (2021)

Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report
por: Rychlíčková, Jitka, et al.
Publicado: (2023)

Comparative effectiveness and safety of anticoagulants for the treatment of heparin‐induced thrombocytopenia
por: Nilius, Henning, et al.
Publicado: (2021)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

Limb ischemia due to spontaneous heparin-induced thrombocytopenia as the primary presentation of acute COVID-19 infection
por: Shiuan, Eileen, et al.
Publicado: (2022)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children
por: Bai, Ke, et al.
Publicado: (2019)

Thrombocytopenia Due to Direct Oral Anticoagulation and Low-Molecular-Weight Heparin
por: Tucker, Madeline, et al.
Publicado: (2021)

Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia
por: Tuleja, Aleksandra, et al.
Publicado: (2022)

Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide
por: Walke, Gulab, et al.
Publicado: (2021)

AZD-1222/fondaparinux sodium: Thrombotic thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
por: Williams, Jonathan S., et al.
Publicado: (2018)

Living kidney transplantation without perioperative anticoagulation therapy for a patient with heparin‐induced thrombocytopenia
por: Nishida, Hayato, et al.
Publicado: (2020)

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist
por: Shimizu, Kazuhiro, et al.
Publicado: (2018)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
por: Zhao, Long, et al.
Publicado: (2021)

Mesenteric Ischemia Caused by Heparin-induced Thrombocytopenia: A Case Report
por: Ahmed, Mohamed, et al.
Publicado: (2019)

How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation
por: Barocas, Antoine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9hdslcd3vc02pd7be494c4rl1r